Abstract
Radiation therapy is crucial for curative treatment of lung cancer, which frequently leads to lung injury. Long non-coding RNAs (lncRNAs) are a group of RNAs longer than 200 nucleotides and lack protein-coding capacity. Increasing evidences demonstrate the important roles of lncRNAs in biological processes. However, the mechanism underlying the association of ionizing radiation with alterations in mRNA and lncRNA expression and lung injury remains unclear. In our study, the male Sprague-Dawley (SD) rats were exposed to a dose of 18 Gy of 6 MV X-ray and the transcriptome spectrum was studied. To identify the differentially expressed mRNAs and lncRNAs induced by X-ray, the RNA sequencing data of lung tissues from irradiated and normal rats for 4, 8, and 16 weeks were analyzed, using |log2_ratio| ≥ 1 and q ≤ 0.05 as thresholds for significantly differential expression. The number of differentially expressed mRNAs was 1097 (686 up- and 411 down-) for 4-week radiotherapy group, 3006 (1935 up- and 1071 down-) for 8-week group and 1838 (1178 up- and 660 down-) for 16-week group. There were 606 (279 up- and 327 down-) differentially expressed lncRNAs in 4-week group, 1715 (831 up- and 884 down-) in 8-week group and 1043 (656 up- and 387 down-) in 16-week group. The differentially expressed mRNAs were mainly involved in cell cycle regulation and Fc receptor pathway, while the lncRNA target genes were significantly enriched in cellular stress response and regulation of cell migration. Moreover, compared with the control group, the irradiated group presented higher tissue specificity of lncRNAs. Radiation-induced lung injury, especially the dynamic network of lncRNAs and mRNAs, is worthy of study. Investigation on the regulatory details of related pathways is significant for the prevention of radiation-related lung injury, as well as the improvement of radiation therapy.
Similar content being viewed by others
Introduction
Radiation therapy is a common and efficient treatment for lung cancer, improving patients’ survival1,2. However, radiation therapy also causes strong side effects in patients such as acute pneumonitis and chronic fibrosis, both of which are fatal3. The side effects of radiation therapy on patients are mainly due to the reactive damages of various cellular components induced by ionizing radiation4,5. Previous studies have found that radiation therapy induces DNA double-strand breaks and other DNA damages, activation of DNA repair reactions and other cellular pathways, such as unfolded protein response (UPR) or autophagy6,7. Activation of these signaling pathways leads to reprogramming of the cellular transcriptional network to restore the structure of the DNA and eliminate damaged cellular components. Investigation of molecular mechanisms underlying radiation therapy damages will help develop new strategies to reduce the side effects for patients with lung cancer.
Previous genetic studies mostly focused on protein-coding RNAs, which account for only 2% of genome transcripts8,9,10,11. For example, cytokines have been proved to play a pivotal role in lung injury induced by radiation and alterations in cytokines levels have been observed both in vitro and in vivo12,13,14. In comparison to the control group, the TGF-β1 level was significantly elevated over time in the lung tissues of irradiated rats15. Obvious difference in angiotensin II expression level was also observed in the lung tissues between irradiated and non-irradiated rats15. Moreover, aberrant expressions, such as sphingolipid metabolic pathway-related genes, p53, and nuclear factor-erythroid-2-related factor, were implicated in radiation induced-lung injury16. These studies suggest that the corresponding mRNAs related to above genes or proteins may act as potentially biomarkers in radiation induced-lung injury. In addition, non-coding RNAs, which were once considered as transcriptional noise, are proved to be implicated multiple physiological and pathological processes, such as tumor development17,18,19. Long non-coding RNAs (lncRNAs) refer to a group of RNAs longer than 200 nucleotides and lacking protein-coding ability. Due to their low abundance, interspecific conservation and high tissue specificity, the researches on lncRNAs, especially on the functional annotations are relatively limited10,20,21,22. An increasing number of studies have revealed that lncRNA is closely involved in various biological processes, including remodeling of chromatin, miRNA sponges, and epigenetic modification11,22,23,24. So, identifying more novel lncRNAs that play important roles in tumor radiotherapy should be helpful for ameliorating the survival of patients after radiation.
Herein, we aimed to investigate the effects of radiation therapy on mRNA and lncRNA expression profiles in rats during the early stage of lung injury induced by radiation, using high-throughput sequencing. As Kampinga HH et al. have shown that Sprague-Dawley rats presented an elevated breathing rate starting 4 weeks after irradiation25, we adopted the Sprague-Dawley rats and selected three time points of 4 weeks, 8 weeks, and 16 weeks to study the transcriptome alterations during the early stage of lung injury induced by radiation. A cohort of differentially expressed mRNAs and lncRNAs induced by radiation in rats’ lung tissues were identified. Functional analysis suggested that differentially expressed mRNAs and lncRNAs were significantly implicated in DNA replicate and cell apoptosis signaling pathways. Moreover, lncRNAs exhibited a higher tissue specificity than mRNAs, which implicated a crucial function of lncRNA in radiotherapy. This study will help identify novel lncRNAs that have important functions in radiation therapy.
Methods and Materials
Study subjects
Animal experiments were granted an exemption from requiring ethics approval with National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science, Peking Union Medical College. Male Sprague-Dawley (SD) rats (4 weeks old) were purchased from the Shanghai SLAC Laboratory Animal Co., Ltd. (Shanghai, China). The animals were housed with a 12-h light/dark cycle with food and water ad libitum. After anesthetized with intra-peritoneally administered 5% Pentobarbital sodium injection, the rats were fixed during radiation exposure. The rats in control group were treated using the same manner with those in experimental group except for the irradiation. The clinical samples were divided into three groups: radiotherapy for 4 weeks (nCon = 4, nexp = 5); radiotherapy for 8 weeks (nCon = 5, nexp = 4); radiotherapy for 16 weeks (nCon = 5, nexp = 5). nCon represented the number of rats in control group and nexp represented that in experimental group.
Radiotherapy
Radiation was applied under general anaesthesia with intra-peritoneally administered 5% Pentobarbital sodium injection. A single dose of 18 Gy with 6 MV photon beams (Varian unique linear accelerator, USA) was applied via a single anterior field to 2 cm depth with source-axis distance technique based on the previous study26. 5 mm bolus was used to build-up the radiation dose on the lung. The radiation field included the right lung. The rats were sacrificed 4 weeks, 8 weeks and 16 weeks after radiation. The rats in the control group did not received radiation and sacrificed at the corresponding time point. The lung tissues were separated and stored at -80 °C for RNA sequencing.
RNA sequencing
In order to explore the effects of radiotherapy in gene expression, rats’ total RNA was extracted and subjected to high-throughput sequencing based on Illumina HiSeq. 2500 platform to obtain RNA expression profile data. Total RNA was extracted from lung tissue samples using TRIzol reagent (Invitrogen) according to the manufacturer’s instruction as previously described27. The RNA was quantified using NanoDrop ND-1000 and assessed using a standard denaturing agarose gel electrophoresis assay. Then 1 μg of total RNA was used with the TruSeq RNA library preparation kit (Illumina) in accordance with low-throughput protocol, except that SuperScript III reverse transcriptase (Invitrogen) was used to synthesize first strand cDNA. After PCR enrichment and purification of adapter-ligated fragments, the concentration of DNA with adapters was determined with quantitative PCR (Applied Biosystems 7,500). Then, RNA sequencing was performed using the Illumina HiSeq. 2500 Sequencing System.
Preprocessing and mapping of sequenced data
In order to ensure the data quality, raw reads were preprocessed by removing low quality sequences, de-junction contamination, rRNA removal, etc to obtain high quality sequences (clean reads) and all subsequent analyses were based on clean reads. Reference gene and genome annotation files were downloaded from the ENSEMBL website (http://www.ensembl.org/index.html). Clean Data was aligned to the reference genome by HISAT2 (http://ccb.jhu.edu/software/hisat2/index.shtml)28. HTSeq (http://www.huber.embl.de/users/anders/HTSeq/doc/overview.html) was used to estimate the expression level of each gene. The quantification of gene expression was performed using FPKM (Fragments Per Kilobase Millon Mapped Reads) method.
Identification of differentially expressed genes
We used the DESseq. 229 package in the R software to screen differentially expressed genes between radiotherapy group and controls. Data were normalized by a negative binomial distribution statistical method. The resulting P values were subjected to multiple test corrections according to the Benjamini and Hochberg methods to exclude false positives. The differentially expressed genes were identified when q ≤ 0.05 and |log2_ratio| ≥ 1.
Screening for novel lncRNAs
We first identified the candidate lncRNAs using the following criterion: (1) reads with more than 200 bp and 2 exons; (2) transcripts with reads coverage ≤5 were excluded; (3) screening out known mRNAs and other non-coding RNAs (rRNA, tRNA, snoRNA, snRNA, etc.) in the samples using Gffcompare (http://ccb.jhu.edu/software/stringtie/gffcompare.shtml); (4) screening potential lincRNA, intronic lncRNA, anti-sense lncRNA according to the class code information (“u”, “i”, “x”) in the comparison results.
The coding ability was an important criterion for identifying lncRNA. Primary screening candidate lncRNAs were synthetically screened using the following softwares: CNCI analysis30, CPC31 analysis, PFAM32 protein domain analysis, CPAT33 analysis. The final novel lncRNA data set was composed of transcripts that were discriminated as non-coding by all four methods.
Prediction for targets of lncRNA
The mRNAs located within 50 kb of the lncRNA were defined as potential cis targets and mRNAs with a correlation coefficient greater than 0.9 were defined as potential trans targets of lncRNA.
Functional enrichment analysis of differentially expressed genes
Gene ontology (GO) analysis was applied to analyze the main function of differentially expressed genes. Based on the number of differentially expressed genes contained in each GO Term, a hypergeometric test was applied to find a significantly enriched GO Term compared to the entire genome background. The calculated P values were corrected by multiple tests. Functional terms with P < 0.05 were considered to be statistically significant.
KEGG (Kyoto Encyclopedia of Genes and Genomes, http://www.kegg.jp/) was a database of genome-wide metabolic pathways. Each pathway was analyzed by a hypergeometric test. The calculated P values were corrected by multiple tests. Pathways with P < 0.05 were considered to be statistically significant enriched.
Tissue-specific analysis of differentially expressed genes
It was generally believed that the tissue specificity of lncRNAs was greater than protein-coding genes. Based on gene expression values, Jensen–Shannon divergence (JS score) of gene in tissues was calculated by a method of information entropy34. The maximum JS score of each gene was considered as its tissue-specific score. The tissue expression bias of genes was positively correlated with tissue-specific scores.
Ethical approval
Animal experiments were granted an exemption from requiring ethics approval with National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science, Peking Union Medical College, the reference number is NCC2018A008.
Results
Sequencing reads quality control and mapping
The basic sequencing and data analysis process was shown in Fig. 1A. The Raw reads were processed for quality control using Btrim to generate high-quality reads. Clean reads were mapped to reference genome and gene expression levels were evaluated. Fig. 1B showed that ∼35% (ranging from 17.93% to 52.71%) of total reads was distributed in the exon region. The remaining reads were mainly distributed in intron region (about 45%) and intergenic region (about 20%), which might be due to alternative splicing, expression noise and so on. The statistical analysis of clean reads indicated that the high-quality data ratio of all samples was above 90% (from 90.65% to 96.59%), except for one sample of C16W-5 (71.46%). Besides, the mapping rates of sequencing rates is high enough (95.11% to 96.43%) for the following analysis.
Gene expression quantification
Gene expression level was characterized by FPKM (Fig. 1C). It was suggested that the expression levels of genes in all samples were overall consistent that suitable for differentially expressed analysis. The gene expression distribution was uniform. The present sequencing data were relatively effective for transcripts with expression levels between 1 and 5.
The similarity of gene expression between samples was also calculated, which indicated all control groups were highly similar, and samples in each experimental group were well clustered together (Fig. 1D). The heat map of whole genome RNA expression was shown in Fig. S1, which indicated that mRNA expression was relatively high and consistently distributed in each sample except for several individual mRNAs and lncRNA expression were relatively low and varied greatly among samples.
Differentially expressed genes induced by radiation
We further analyzed differentially expressed genes induced by radiation. From the heatmap in Fig. S1, one could intuitively observe a different expression pattern between radiation and control groups. Gene expression values between the radiation group and control group were compared using DESeq. 2. The distribution of differentially expressed genes was represented by a volcano map (Fig. 2A). Fig. 2B showed the total number of differentially expressed genes in three time points, which was 1097 (686 up- and 411 down-) for 4-week radiotherapy group, 3006 (1935 up- and 1071 down-) for 8-week group and 1838 (1178 up- and 660 down-) for 16-week group. Besides, differentially expressed genes had a certain intersection between different groups (Fig. 2C). The shared differentially expressed genes were 1029 between 4-week and 8-week group, 453 for 4-week and 16-week and 679 for 4-week and 8-week. A total of 396 differentially expressed genes were shared by three groups, which were listed in Table S1, including annotation and gene expression information.
In order to obtain a more reliable novel lncRNA set, we used CNCI, CPC, PFAM, and CPAT to evaluate the coding potential of lncRNAs. The shared lncRNAs was used as the final novel lncRNA set, which finally resulted in a total of 54,837 lncRNAs (Fig. 3A). The transcript length and the number of exons in novel lncRNAs were shown in Fig. S2. The transcript length of novel lncRNA was mainly below 20 kb and exon number were distributed within 1-3, which was consistent with the typical characteristics of lncRNAs.
We further performed a structural analysis of lncRNAs and mRNAs (Fig. 3B bottom and upper panel, respectively). It was suggested that the transcript length and exon number of lncRNAs were significantly lower than those of mRNAs. The expression levels of mRNA and lncRNA in each sample was shown in Fig. S3, which indicated that the expression level of lncRNAs was significantly lower than that of mRNAs. Fig. 3C showed differentially expressed mRNAs and lncRNAs in different groups. There were 491 differentially expressed mRNAs (407 up- and 84 down-) and 606 lncRNAs (279 up- and 327 down-) in 4-week group. 1291 differentially expressed mRNAs (1104 up- and 187 down-) and 1715 lncRNAs (831 up- and 884 down-) were found in 8-week group. 795 differentially expressed mRNAs (522 up- and 273 down-) and 1043 lncRNAs (656 up- and 387 down-) were found in 16-week group.
To determine the primary functions of the differentially expressed genes, GO and KEGG pathway analysis was performed. As shown in Fig. 3D, signaling pathways were significantly enriched by the differentially expressed genes, including B cell mediated immunity, DNA integrity checkpoint, DNA packaging and DNA replication in 4-week group, B cell receptor signaling pathway, DNA replication related and Fc receptor related projects in 8-week group and Fc receptor mediated stimulatory signaling pathway, Fc receptor signaling pathway and other projects in 16-week group. For KEGG pathway, the differentially expressed genes of three groups were enriched in the metabolic pathways such as complement and coagulation cascades, Staphylococcus aureus infection, cytokine−cytokine receptor interaction and Malaria. A complete list of GO items for differentially expressed mRNA enrichment was shown in Fig. S4, mainly including three categories: biological processes, molecular functions, and cellular components.
LncRNA functions mainly through cis- or trans-acting on protein-coding genes. The statistical information of predicted target genes of lncRNAs was showed in Table S2. The functional enrichment analysis of cis- and trans- target of the differentially expressed lncRNAs were performed (Fig. 3E). The GO terms were mainly enriched in cell chemotaxis and cell migration pathways in 4-week group, catabolic process and cellular response related projects in 8-week group and cellular response related projects in 16-week group. For KEGG pathway, the target genes of lncRNAs were not significantly enriched. A complete list of GO items of target gene enrichment was shown in Fig. S5, which mainly included three categories: biological processes, molecular functions and cellular components. The predicted regulatory network among mRNA, lncRNA, and lncRNA target genes was shown in Fig. S6. The circles represented differentially expressed lncRNAs, and the squares represented their target genes and mRNAs. Upregulation was denoted by yellow, and downregulation was denoted by navy blue. It was indicated that the regulatory network of 8-week group was the most complex, while 4-week group presented a relatively simple regulatory network.
Tissue specificity analysis
We next analyzed the tissue specificity of differentially expressed mRNAs and lncRNAs. The density distribution curve showed that lncRNAs had a significantly higher JS score than that of mRNAs (Fig. 4A), which was consistent with the strong tissue-specific expression of lncRNAs.
There were 73, 46, and 62 tissue-specific mRNAs (JS < 0.5) in 4-, 8- and 16-week groups, respectively (Fig. 4B). While the number of tissue-specific lncRNAs was respectively 488, 236 and 335 in 4-, 8- and 16-week groups, which indicated that lncRNAs had a higher tissue specificity than mRNAs. There were no significant differences in the number of tissue-specific mRNAs between the experimental and control groups in three groups. While, the number of tissue-specific lncRNAs in the experimental groups in the three groups was about twice that of the control group, suggesting that lncRNA might play an important role in radiotherapy. The information of tissue-specifically expressed mRNAs and lncRNAs were showed in Table S3 and Table S4.
The heat map in Fig. 4C showed the expression of tissue-specific mRNAs (JS > 0.5) in each sample and the expression of tissue-specific lncRNAs (JS > 0.5) was shown in Fig. 4D. The results showed that the tissue specificity of lncRNAs experimental groups was significantly higher than that in control groups, suggesting that lncRNA may play an important biological function in the experimental group.
Discussion
Although radiotherapy effectively inhibits tumor growth in lung cancer patients, it also causes severe lung injury. To explore the molecular mechanism of radiotherapy for lung injury, we used RNA-seq to identify mRNA and lncRNA expression profile changes induced by radiation therapy in rats’ lung tissues. Comparing the transcriptome profiles in response to irradiation, we identified 491 (407 up- and 84 down-) differentially expressed mRNAs and 606 lncRNAs (279 up- and 327 down-) between the irradiated and control groups when radiotherapy for 4 weeks. 1291 differentially expressed mRNAs (1104 up- and 187 down-) and 1715 lncRNAs (831 up- and 884 down-) were found in 8-week group and 795 differentially expressed mRNAs (522 up- and 273 down-) and 1043 lncRNAs (656 up- and 387 down-) were found in 16-week group. There were 396 common differentially expressed genes (including mRNAs and lncRNAs) among the 4-week, 8-week and 16-week groups. Besides, compared with mRNAs, lncRNAs had shorter transcript length and less exon number, which was consistent with the general characteristics of lncRNAs. It is suggested that lncRNAs are genetic regulators of several biological processes, such as radiation-induced lung injury, and the differentially expressed lncRNAs are involved in this process by targeting related genes. For example, LIRR1, a differentially expressed lncRNA in radiation-induced lung injury, was associated with the altered expressions of KU70, KU80, RAD50, and MDM235. Thus, the differentially expressed lncRNAs we screened might be significant biomarkers of radiation-induced lung injury.
Subsequently, the functions of the differentially expressed mRNAs and lncRNAs were analyzed. It was suggested that the differentially expressed mRNAs were implicated in several cellular processes including B cell mediated immunity, DNA integrity checkpoint, DNA packaging and DNA replication in 4-week group and Fc receptor signaling pathway in 8-week and 16-week groups. Cell cycle checkpoints play a critical role in orderly progression via regulating cell division36,37. These pathways respond to the adverse conditions by delaying or arresting cell cycles. It is indicated that the DNA damage checkpoint can arrest the cell cycle in order to suppress damaged DNA replication and chromosomes segregation that result in aneuploidy or instability of the genome36,37,38. DNA damage checkpoint consists of the following procedures: initiation, maintenance, and recovery, involving in multiple processes such as DNA lesion detection, signaling pathway activation, checkpoint signal maintenance, and checkpoint signal attenuation after repairment of DNA lesion. The procedures above are properly modulated to ensure the correct cooperation between cells and DNA damage events. Fc receptor, observed in various cells such as B lymphocytes and macrophages, is able to bind to the Fc region of antibodies and plays a protective role the immune system39,40,41. It is known that Fc receptor targets the antibodies that are attached to invading pathogens or infected cells, and induces destruction of microbes or infected cells via phagocytosis or cytotoxicity27,28,29. Therefore, we hypothesized that radiation therapy mainly contributed to arrestment of cell cycle and activation of the immune system in lung tissue. KEGG analysis results revealed that differentially expressed mRNAs were mainly involved in complement and coagulation cascades, staphylococcus aureus infection and cytokine−cytokine receptor interaction. GO analysis indicated that lncRNA target genes were associated with the regulation of cell migration and cellular stress response. However, for KEGG pathway, the lncRNAs target genes were not strikingly enriched. Furthermore, compared with control group, the tissue specificity of lncRNAs induced by radiation was significantly higher, suggesting that lncRNAs probably played a pivotal role in lung injury mechanism.
Conclusions
A large amount of mRNAs and lncRNAs in the lung injury induced by radiation were identified in our study. Meanwhile, possible cell cycle regulation and immunological function for them were found during the pathogenesis of lung injury. Our results provided interesting clues on the mechanism of lung injury induced by radiation. Currently, the detailed effects of lncRNAs in radiation-induced lung injury have not been fully investigated yet, thus, our study might also provide promising information for future researches. As the current study aims to provide an overall analysis of the mRNAs and lncRNAs associated with early stage radiation-induced lung injury over time, our follow-up research would focus on several biomarkers from the significant mRNAs and lncRNAs screened to further investigate their specific roles in early stage of lung injury induced by radiation.
Data availability
All data generated or analyzed during this study are included in this published article.
References
Jeter, M. D., Komaki, R., & Cox, J. D. Radiation Time, Dose, and Fractionation in the Treatment of Lung Cancer. Advances in Radiation Oncology in Lung Cancer. Springer Berlin Heidelberg (2011).
Zhu, H. et al. Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis. Cancer 117, 5423–5431 (2011).
Yang, H. J., Kim, N., Seong, K. M., Youn, H. & Youn, B. Investigation of Radiation-induced Transcriptome Profile of Radioresistant Non-small Cell Lung Cancer A549 Cells Using RNA-seq. Plos One. 8 (2013).
Luo, J., et al. Profiling circRNA and miRNA of radiation-induced esophageal injury in a rat model. Scientific Reports. 8 (2018).
Kwon, H. M. et al. Combinatorial effects of an epigenetic inhibitor and ionizing radiation contribute to targeted elimination of pancreatic cancer stem cell. Oncotarget. 8, 89005–89020 (2017).
Hayes, J. et al. A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab. Molecular Oncology. 10, 1296–1304 (2016).
Szołtysek, Katarzyna et al. Rrad, il4i1, cdkn1a, and serpine1 genes are potentially co-regulated by nf-κb and p53 transcription factors in cells exposed to high doses of ionizing radiation. BMC Genomics. 19, 813 (2018).
Chen, G. et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res 41, D983–986 (2013).
Hangauer., M. J., Vaughn, I. W. & McManus, M. T. Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet. 9, e1003569 (2013).
Necsulea, A. et al. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature. 505, 635–640 (2014).
Ulitsky, I. & Bartel, D. P. LincRNAs: genomics, evolution, and mechanisms. Cell. 154, 26–46 (2013).
Barthelemy-Brichant, N., Lionel, Bosquée, Cataldo, D., Corhay, J. L. & Nusgens, B. Increased il-6 and tgf-β1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. International Journal of Radiation OncologyBiologyPhysics 58, 758–767 (2004).
Hart, J. P. et al. Cytokine profiling for prediction of symptomatic radiation-induced lung injury. International Journal of Radiation Oncology Biology Physics 63, 1448–1454 (2005).
Hong, Z., Song, K., Story, M. & Cho, J. An experimental model-based biomarker exploration of radiation-induced lung injury in vivo and in vitro. International Journal of Radiation Oncology*Biology*Physics 87, S664 (2013).
Cao, S. & Wu, R. Expression of angiotensin ii and aldosterone in radiation-induced lung injury. Cancer Biology and Medicine 9, 254–260 (2012).
Simvastatin attenuates radiation-induced murine lung injury and dysregulated lung gene expression. American Journal of Respiratory Cell and Molecular Biology, 44, 415–422(2011).
Das, M., et al. DDX5/p68 associated lncRNA LOC284454 is differentially expressed in human cancers and modulates gene expression. RNA Biol. 1–17 (2017).
Ning, Q. et al. The Evolution and Expression Pattern of Human Overlapping lncRNA and Protein-coding Gene Pairs. Scientific reports 7, 42775 (2017).
Zhang, H. et al. Expression of Long Non-Coding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) Exacerbates Hepatocellular Carcinoma Through Suppressing miR-195. Med Sci Monit 22, 4820–4829 (2016).
Mitra, S. A., Mitra, A. P. & Triche, T. J. A central role for long non-coding RNA in cancer. Front Genet. 3, 17 (2012).
Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775–1789 (2012).
Liu, J. et al. Genome-wide analysis uncovers regulation of long intergenic noncoding RNAs in Arabidopsis. Plant Cell. 24, 4333–4345 (2012).
Rinn, J. L. & Chang, H. Y. Genome regulation by long noncoding RNAs. Annu Rev Biochem 81, 145–166 (2012).
Hellwig, S. & Bass, B. L. A starvation-induced noncoding RNA modulates expression of Dicer-regulated genes. Proc Natl Acad Sci U S A 105, 12897–12902 (2008).
Eerde, M. R. V., Kampinga, H. H., Szabo, B. G. & Vujaskovic, Z. Comparison of three rat strains for development of radiation-induced lung injury after hemithoracic irradiation. Radiotherapy and Oncology 58, 313–316 (2001).
Xie, L. et al. Integrating microrna and mrna expression profiles in response to radiation-induced injury in rat lung. Radiation Oncology 9, 111 (2014).
Liu, Y., Zhang, C., Fan, J., Xiao, L. & Xia, S. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer. World Journal of Surgical Oncology 9, 121 (2011).
Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nature Methods. 12, 357–U121 (2015).
Chang, L. C. et al. RefCNV: Identification of Gene-Based Copy Number Variants Using Whole Exome Sequencing. Cancer informatics. 15, 65–71 (2016).
Sun, L. et al. Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucleic Acids Research. 41, e166 (2013).
Kong, L. et al. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Research 35, W345–W349 (2007).
Mistry, J., Bateman, A. & Finn, R. D. Predicting active site residue annotations in the Pfam database. Bmc Bioinformatics. 8, 298 (2007).
Wang, L. et al. CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Research. 41, e74 (2013).
Cabili, M. N. et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes &. Development. 25, 1915–1927 (2011).
Jiao, Y. et al. Long intergenic non-coding rna induced by x-ray irradiation regulates dna damage response signaling in the human bronchial epithelial beas-2b cell line. Oncology Letters 9, 169–176 (2014).
Wood, M. D. & Sanchez, Y. Deregulated Ras signaling compromises DNA damage checkpoint recovery in S. cerevisiae. Cell Cycle. 9, 3353–3363 (2010).
Yilmaz, S., Sancar, A. & Kemp, M. G. Multiple ATR-Chk1 Pathway Proteins Preferentially Associate with Checkpoint-Inducing DNA Substrates. Plos One. 6, e22986 (2011).
Lowndes, N. F. & Murguia, J. R. Sensing and responding to DNA damage. Current Opinion in Genetics & Development 10, 17–25 (2000).
Ninomiya, N. et al. Involvement of phosphatidylinositol 3-kinase in Fc gamma receptor signaling. Journal of Biological Chemistry 269, 22732–22737 (1994).
Kaneko, Y., Nimmerjahn, F. & Ravetch, J. V. Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation. Science. 313, 670 (2006).
Daëron, M. Fc receptor biology. Annual Review of Immunology 15, 203 (1997).
Acknowledgements
This study was supported by the CAMS Innovation Fund for Medical Sciences [grant number 2017-I2M-1-009].
Author information
Authors and Affiliations
Contributions
Tao Zhang made substantial contributions to conception and design, acquisition of data, analysis and interpretation of data; Guowei Cheng and Li Sun performed the experiments; Lei Deng have been involved in drafting the manuscript or revising it critically for important intellectual content; Xin Wang given final approval of the version to be published. Nan Bi agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, T., Cheng, G., Sun, L. et al. Transcriptome alteration spectrum in rat lung induced by radiotherapy. Sci Rep 9, 19701 (2019). https://doi.org/10.1038/s41598-019-56027-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-56027-4
- Springer Nature Limited